NeuroOne Medical Technologies Corporation (NMTC) Total liabilities 2016–2025
NeuroOne Medical Technologies Corporation (NMTC) total liabilities at each fiscal year-end, per SEC filings.
$3.7MFY2025 · since FY2016: $1.0M → $3.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $3.7M | -18.4% |
| FY2024 | $4.5M | +146.1% |
| FY2023 | $1.8M | -42.6% |
| FY2022 | $3.2M | +132.4% |
| FY2021 | $1.4M | — |
| FY2016 | $1.0M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More NMTC financial trends
NMTC RevenueNMTC Net incomeNMTC Net marginNMTC Gross profitNMTC Gross marginNMTC Operating incomeNMTC Operating marginNMTC Operating cash flowNMTC Free cash flowNMTC Capital expendituresNMTC Return on equityNMTC Stock buybacksNMTC Dividends paidNMTC Total assetsNMTC Shareholders’ equityNMTC overview →